{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:46:41Z","timestamp":1790192801027,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00467-018-4039-7","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T11:34:34Z","timestamp":1534246474000},"page":"1337-1348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Extra-renal manifestations of atypical hemolytic uremic syndrome"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9814-9334","authenticated-orcid":false,"given":"Cassandra","family":"Formeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Swiatecka-Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"4039_CR1","first-page":"5","volume":"3","author":"M Ohanian","year":"2011","unstructured":"Ohanian M, Cable C, Halka K (2011) Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome. Clin Pharmacol 3:5\u201312","journal-title":"Clin Pharmacol"},{"key":"4039_CR2","first-page":"441","volume":"68","author":"V Talarico","year":"2016","unstructured":"Talarico V, Aloe M, Monzani A, Miniero R, Bona G (2016) Hemolytic uremic syndrome in children. Minerva Pediatr 68:441\u2013455","journal-title":"Minerva Pediatr"},{"key":"4039_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","volume":"148","author":"CM Taylor","year":"2010","unstructured":"Taylor CM, Machin S, Wigmore SJ, Goodship TH, working party from the Renal Association tBCfSiH, the British Transplantation S (2010) Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom. Br J Haematol 148:37\u201347","journal-title":"Br J Haematol"},{"key":"4039_CR4","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00467-012-2131-y","volume":"27","author":"LM Geerdink","year":"2012","unstructured":"Geerdink LM, Westra D, van Wijk JA, Dorresteijn EM, Lilien MR, Davin JC, Komhoff M, Van Hoeck K, van der Vlugt A, van den Heuvel LP, van de Kar NC (2012) Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics. Pediatr Nephrol 27:1283\u20131291","journal-title":"Pediatr Nephrol"},{"key":"4039_CR5","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","volume":"5","author":"M Noris","year":"2010","unstructured":"Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G (2010) Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin J Am Soc Nephrol 5:1844\u20131859","journal-title":"Clin J Am Soc Nephrol"},{"key":"4039_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2215\/CJN.04760512","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","unstructured":"Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaime F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Deschenes G, Lebranchu Y, Zuber J, Loirat C (2013) Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 8:554\u2013562","journal-title":"Clin J Am Soc Nephrol"},{"key":"4039_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1681\/ASN.2013050453","volume":"25","author":"F Bu","year":"2014","unstructured":"Bu F, Maga T, Meyer NC, Wang K, Thomas CP, Nester CM, Smith RJ (2014) Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J Am Soc Nephrol 25:55\u201364","journal-title":"J Am Soc Nephrol"},{"key":"4039_CR8","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.4049\/jimmunol.160.12.6128","volume":"160","author":"EJ Hindmarsh","year":"1998","unstructured":"Hindmarsh EJ, Marks RM (1998) Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells. J Immunol 160:6128\u20136136","journal-title":"J Immunol"},{"key":"4039_CR9","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1182\/blood-2013-11-516237","volume":"123","author":"SR Cataland","year":"2014","unstructured":"Cataland SR, Wu HM (2014) How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome. Blood 123:2478\u20132484","journal-title":"Blood"},{"key":"4039_CR10","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1172\/JCI16651","volume":"111","author":"T Manuelian","year":"2003","unstructured":"Manuelian T, Hellwage J, Meri S, Caprioli J, Noris M, Heinen S, Jozsi M, Neumann HP, Remuzzi G, Zipfel PF (2003) Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest 111:1181\u20131190","journal-title":"J Clin Invest"},{"key":"4039_CR11","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.4049\/jimmunol.177.7.4794","volume":"177","author":"K Ritis","year":"2006","unstructured":"Ritis K, Doumas M, Mastellos D, Micheli A, Giaglis S, Magotti P, Rafail S, Kartalis G, Sideras P, Lambris JD (2006) A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol 177:4794\u20134802","journal-title":"J Immunol"},{"key":"4039_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneph.2012.195","volume":"8","author":"M Noris","year":"2012","unstructured":"Noris M, Mescia F, Remuzzi G (2012) STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol 8:622\u2013633","journal-title":"Nat Rev Nephrol"},{"key":"4039_CR13","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1182\/blood-2014-09-600411","volume":"125","author":"R Cofiell","year":"2015","unstructured":"Cofiell R, Kukreja A, Bedard K, Yan Y, Mickle AP, Ogawa M, Bedrosian CL, Faas SJ (2015) Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS. Blood 125:3253\u20133262","journal-title":"Blood"},{"key":"4039_CR14","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361:1676\u20131687","journal-title":"N Engl J Med"},{"key":"4039_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fped.2014.00097","volume":"2","author":"J Hofer","year":"2014","unstructured":"Hofer J, Rosales A, Fischer C, Giner T (2014) Extra-renal manifestations of complement-mediated thrombotic microangiopathies. Front Pediatr 2:97","journal-title":"Front Pediatr"},{"key":"4039_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-015-3076-8","volume":"31","author":"C Loirat","year":"2016","unstructured":"Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A, Coppo R, Emma F, Johnson S, Karpman D, Landau D, Langman CB, Lapeyraque AL, Licht C, Nester C, Pecoraro C, Riedl M, van de Kar NC, Van de Walle J, Vivarelli M, Fremeaux-Bacchi V, International HUS (2016) An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatr Nephrol 31:15\u201339","journal-title":"Pediatr Nephrol"},{"key":"4039_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1750-1172-6-60","volume":"6","author":"C Loirat","year":"2011","unstructured":"Loirat C, Fremeaux-Bacchi V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6:60","journal-title":"Orphanet J Rare Dis"},{"key":"4039_CR18","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1681\/ASN.2010030315","volume":"21","author":"MA Dragon-Durey","year":"2010","unstructured":"Dragon-Durey MA, Sethi SK, Bagga A, Blanc C, Blouin J, Ranchin B, Andre JL, Takagi N, Cheong HI, Hari P, Le Quintrec M, Niaudet P, Loirat C, Fridman WH, Fremeaux-Bacchi V (2010) Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. J Am Soc Nephrol 21:2180\u20132187","journal-title":"J Am Soc Nephrol"},{"key":"4039_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12882-016-0420-6","volume":"18","author":"N Besbas","year":"2017","unstructured":"Besbas N, Gulhan B, Soylemezoglu O, Ozcakar ZB, Korkmaz E, Hayran M, Ozaltin F (2017) Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients. BMC Nephrol 18:6","journal-title":"BMC Nephrol"},{"key":"4039_CR20","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.kint.2017.04.028","volume":"92","author":"V Brocklebank","year":"2017","unstructured":"Brocklebank V, Johnson S, Sheerin TP, Marks SD, Gilbert RD, Tyerman K, Kinoshita M, Awan A, Kaur A, Webb N, Hegde S, Finlay E, Fitzpatrick M, Walsh PR, Wong EKS, Booth C, Kerecuk L, Salama AD, Almond M, Inward C, Goodship TH, Sheerin NS, Marchbank KJ, Kavanagh D (2017) Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland. Kidney Int 92:1261\u20131271","journal-title":"Kidney Int"},{"key":"4039_CR21","doi-asserted-by":"publisher","first-page":"P363","DOI":"10.1186\/1546-0096-12-S1-P363","volume":"12","author":"R Shiari","year":"2014","unstructured":"Shiari R, Parvaneh VJ, Dalirani R, Farivar S, Shiva MR (2014) Atypical hemolytic-uremic syndrome associated with antiphospholipid antibodies and antiphospholipid syndrome; a novel presentation. Pediatric Rheumatology 12:P363","journal-title":"Pediatric Rheumatology"},{"key":"4039_CR22","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1136\/adc.76.6.518","volume":"76","author":"TJ Neuhaus","year":"1997","unstructured":"Neuhaus TJ, Calonder S, Leumann EP (1997) Heterogeneity of atypical haemolytic uraemic syndromes. Arch Dis Child 76:518\u2013521","journal-title":"Arch Dis Child"},{"key":"4039_CR23","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-014-2817-4","volume":"29","author":"S Johnson","year":"2014","unstructured":"Johnson S, Stojanovic J, Ariceta G, Bitzan M, Besbas N, Frieling M, Karpman D, Landau D, Langman C, Licht C, Pecoraro C, Riedl M, Siomou E, van de Kar N, Walle JV, Loirat C, Taylor CM (2014) An audit analysis of a guideline for the investigation and initial therapy of diarrhea negative (atypical) hemolytic uremic syndrome. Pediatr Nephrol 29:1967\u20131978","journal-title":"Pediatr Nephrol"},{"key":"4039_CR24","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s00467-018-3933-3","volume":"33","author":"K Fidan","year":"2018","unstructured":"Fidan K, Goknar N, Gulhan B, Melek E, Yildirim ZY, Baskin E, Hayran M, Gulleroglu K, Ozcakar ZB, Ozaltin F, Soylemezoglu O (2018) Extra-Renal manifestations of atypical hemolytic uremic syndrome in children. Pediatr Nephrol 33:1395\u20131403","journal-title":"Pediatr Nephrol"},{"key":"4039_CR25","doi-asserted-by":"publisher","first-page":"e1764","DOI":"10.1542\/peds.2013-1594","volume":"133","author":"B Diamante Chiodini","year":"2014","unstructured":"Diamante Chiodini B, Davin JC, Corazza F, Khaldi K, Dahan K, Ismaili K, Adams B (2014) Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome. Pediatrics 133:e1764\u2013e1768","journal-title":"Pediatrics"},{"key":"4039_CR26","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00467-013-2416-9","volume":"28","author":"K Gulleroglu","year":"2013","unstructured":"Gulleroglu K, Fidan K, Hancer VS, Bayrakci U, Baskin E, Soylemezoglu O (2013) Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab. Pediatr Nephrol 28:827\u2013830","journal-title":"Pediatr Nephrol"},{"key":"4039_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00277-012-1615-y","volume":"92","author":"G Salem","year":"2013","unstructured":"Salem G, Flynn JM, Cataland SR (2013) Profound neurological injury in a patient with atypical hemolytic uremic syndrome. Ann Hematol 92:557\u2013558","journal-title":"Ann Hematol"},{"key":"4039_CR28","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s00467-010-1606-y","volume":"25","author":"B Koehl","year":"2010","unstructured":"Koehl B, Boyer O, Biebuyck-Gouge N, Kossorotoff M, Fremeaux-Bacchi V, Boddaert N, Niaudet P (2010) Neurological involvement in a child with atypical hemolytic uremic syndrome. Pediatr Nephrol 25:2539\u20132542","journal-title":"Pediatr Nephrol"},{"key":"4039_CR29","doi-asserted-by":"publisher","first-page":"295323","DOI":"10.1155\/2014\/295323","volume":"2014","author":"HM Tsai","year":"2014","unstructured":"Tsai HM, Kuo E (2014) Eculizumab therapy leads to rapid resolution of thrombocytopenia in atypical hemolytic uremic syndrome. Adv Hematol 2014:295323","journal-title":"Adv Hematol"},{"key":"4039_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nrneph.2013.280","volume":"10","author":"M Noris","year":"2014","unstructured":"Noris M, Remuzzi G (2014) Cardiovascular complications in atypical haemolytic uraemic syndrome. Nat Rev Nephrol 10:174\u2013180","journal-title":"Nat Rev Nephrol"},{"key":"4039_CR31","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00467-012-2276-8","volume":"27","author":"R Vilalta","year":"2012","unstructured":"Vilalta R, Lara E, Madrid A, Chocron S, Munoz M, Casquero A, Nieto J (2012) Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome. Pediatr Nephrol 27:2323\u20132326","journal-title":"Pediatr Nephrol"},{"key":"4039_CR32","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1093\/ndt\/gfq160","volume":"25","author":"M Sallee","year":"2010","unstructured":"Sallee M, Daniel L, Piercecchi MD, Jaubert D, Fremeaux-Bacchi V, Berland Y, Burtey S (2010) Myocardial infarction is a complication of factor H-associated atypical HUS. Nephrol Dial Transplant 25:2028\u20132032","journal-title":"Nephrol Dial Transplant"},{"key":"4039_CR33","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00467-013-2709-z","volume":"29","author":"H Hu","year":"2014","unstructured":"Hu H, Nagra A, Haq MR, Gilbert RD (2014) Eculizumab in atypical haemolytic uraemic syndrome with severe cardiac and neurological involvement. Pediatr Nephrol 29:1103\u20131106","journal-title":"Pediatr Nephrol"},{"key":"4039_CR34","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1093\/ndt\/gfq319","volume":"25","author":"C Loirat","year":"2010","unstructured":"Loirat C, Macher MA, Elmaleh-Berges M, Kwon T, Deschenes G, Goodship TH, Majoie C, Davin JC, Blanc R, Savatovsky J, Moret J, Fremeaux-Bacchi V (2010) Non-atheromatous arterial stenoses in atypical haemolytic uraemic syndrome associated with complement dysregulation. Nephrol Dial Transplant 25:3421\u20133425","journal-title":"Nephrol Dial Transplant"},{"key":"4039_CR35","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1053\/j.ajkd.2009.08.011","volume":"55","author":"JC Davin","year":"2010","unstructured":"Davin JC, Gracchi V, Bouts A, Groothoff J, Strain L, Goodship T (2010) Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation. Am J Kidney Dis 55:708\u2013711","journal-title":"Am J Kidney Dis"},{"key":"4039_CR36","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.3174\/ajnr.A0965","volume":"29","author":"MD Vergouwen","year":"2008","unstructured":"Vergouwen MD, Adriani KS, Roos YB, Groothoff JW, Majoie CB (2008) Proximal cerebral artery stenosis in a patient with hemolytic uremic syndrome. AJNR Am J Neuroradiol 29:e34","journal-title":"AJNR Am J Neuroradiol"},{"key":"4039_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00467-010-1608-9","volume":"26","author":"JC Davin","year":"2011","unstructured":"Davin JC, Majoie C, Groothoff J, Gracchi V, Bouts A, Goodship TH, Loirat C (2011) Prevention of large-vessel stenoses in atypical hemolytic uremic syndrome associated with complement dysregulation. Pediatr Nephrol 26:155\u2013157","journal-title":"Pediatr Nephrol"},{"key":"4039_CR38","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1093\/ndt\/gft340","volume":"28","author":"ZD Bekassy","year":"2013","unstructured":"Bekassy ZD, Kristoffersson AC, Cronqvist M, Roumenina LT, Rybkine T, Vergoz L, Hue C, Fremeaux-Bacchi V, Karpman D (2013) Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions. Nephrol Dial Transplant 28:2899\u20132907","journal-title":"Nephrol Dial Transplant"},{"key":"4039_CR39","doi-asserted-by":"publisher","unstructured":"Bhatti NK, Karimi Galougahi K, Paz Y, Nazif T, Moses JW, Leon MB, Stone GW, Kirtane AJ, Karmpaliotis D, Bokhari S, Hardy MA, Dube G, Mohan S, Ratner LE, Cohen DJ, Ali ZA (2016) Diagnosis and management of cardiovascular disease in Advanced and End-Stage Renal Disease. J Am Heart Assoc https:\/\/doi.org\/10.1161\/JAHA.116.003648 .","DOI":"10.1161\/JAHA.116.003648"},{"key":"4039_CR40","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/imj.12864","volume":"45","author":"A Mallett","year":"2015","unstructured":"Mallett A, Hughes P, Szer J, Tuckfield A, Van Eps C, Cambell SB, Hawley C, Burke J, Kausman J, Hewitt I, Parnham A, Ford S, Isbel N (2015) Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort. Intern Med J 45:1054\u20131065","journal-title":"Intern Med J"},{"key":"4039_CR41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/ajt.12077","volume":"13","author":"M Quintrec Le","year":"2013","unstructured":"Le Quintrec M, Zuber J, Moulin B, Kamar N, Jablonski M, Lionet A, Chatelet V, Mousson C, Mourad G, Bridoux F, Cassuto E, Loirat C, Rondeau E, Delahousse M, Fremeaux-Bacchi V (2013) Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome. Am J Transplant 13:663\u2013675","journal-title":"Am J Transplant"},{"key":"4039_CR42","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1182\/blood-2011-10-383281","volume":"119","author":"LT Roumenina","year":"2012","unstructured":"Roumenina LT, Frimat M, Miller EC, Provot F, Dragon-Durey MA, Bordereau P, Bigot S, Hue C, Satchell SC, Mathieson PW, Mousson C, Noel C, Sautes-Fridman C, Halbwachs-Mecarelli L, Atkinson JP, Lionet A, Fremeaux-Bacchi V (2012) A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 119:4182\u20134191","journal-title":"Blood"},{"key":"4039_CR43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00467-002-0973-4","volume":"18","author":"A Ozel","year":"2003","unstructured":"Ozel A, Caliskan U, Gucer S (2003) Peripheral gangrene complicating hemolytic uremic syndrome in a child. Pediatr Nephrol 18:465\u2013467","journal-title":"Pediatr Nephrol"},{"key":"4039_CR44","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1053\/j.ajkd.2013.09.020","volume":"63","author":"G Ardissino","year":"2014","unstructured":"Ardissino G, Tel F, Testa S, Marzano AV, Lazzari R, Salardi S, Edefonti A (2014) Skin involvement in atypical hemolytic uremic syndrome. Am J Kidney Dis 63:652\u2013655","journal-title":"Am J Kidney Dis"},{"key":"4039_CR45","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s004670050058","volume":"14","author":"BS Kaplan","year":"2000","unstructured":"Kaplan BS, Garcia CD, Chesney RW, Segar WE, Giugno K, Chem R (2000) Peripheral gangrene complicating idiopathic and recessive hemolytic uremic syndromes. Pediatr Nephrol 14:985\u2013989","journal-title":"Pediatr Nephrol"},{"key":"4039_CR46","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1542\/peds.2012-0903","volume":"131","author":"M Malina","year":"2013","unstructured":"Malina M, Gulati A, Bagga A, Majid MA, Simkova E, Schaefer F (2013) Peripheral gangrene in children with atypical hemolytic uremic syndrome. Pediatrics 131:e331\u2013e335","journal-title":"Pediatrics"},{"key":"4039_CR47","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1755-3768.2009.01552.x","volume":"88","author":"V Sturm","year":"2010","unstructured":"Sturm V, Menke MN, Landau K, Laube GF, Neuhaus TJ (2010) Ocular involvement in paediatric haemolytic uraemic syndrome. Acta Ophthalmol 88:804\u2013807","journal-title":"Acta Ophthalmol"},{"key":"4039_CR48","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.3928\/01913913-20140923-03","volume":"51","author":"X Zheng","year":"2014","unstructured":"Zheng X, Gorovoy IR, Mao J, Jin J, Chen X, Cui QN (2014) Recurrent ocular involvement in pediatric atypical hemolytic uremic syndrome. J Pediatr Ophthalmol Strabismus 51:e62\u2013e65","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"4039_CR49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2147\/IMCRJ.S90640","volume":"8","author":"GT Greenwood","year":"2015","unstructured":"Greenwood GT (2015) Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab. Int Med Case Rep J 8:235\u2013239","journal-title":"Int Med Case Rep J"},{"key":"4039_CR50","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s00467-007-0540-0","volume":"22","author":"A Larakeb","year":"2007","unstructured":"Larakeb A, Leroy S, Fremeaux-Bacchi V, Montchilova M, Pelosse B, Dunand O, Deschenes G, Bensman A, Ulinski T (2007) Ocular involvement in hemolytic uremic syndrome due to factor H deficiency--are there therapeutic consequences? Pediatr Nephrol 22:1967\u20131970","journal-title":"Pediatr Nephrol"},{"key":"4039_CR51","first-page":"399","volume":"38","author":"JE Ramos de Carvalho","year":"2017","unstructured":"Ramos de Carvalho JE, Schlingemann RO, Oranje M, Bemelman FJ, van Schooneveld MJ (2017) Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome. Int Ophthalmol 38:399\u2013407","journal-title":"Int Ophthalmol"},{"key":"4039_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.amjms.2016.05.003","volume":"352","author":"BE Berger","year":"2016","unstructured":"Berger BE (2016) The Alternative Pathway of Complement and the Evolving Clinical-Pathophysiological spectrum of Atypical Hemolytic Uremic Syndrome. Am J Med Sci 352:177\u2013190","journal-title":"Am J Med Sci"},{"key":"4039_CR53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.14740\/jh205w","volume":"4","author":"J Yao De","year":"2015","unstructured":"De Yao J, Kaplan R, Magro C (2015) An Atypical Case of Atypical Hemolytic Uremic Syndrome: Predominant Gastrointestinal Involvement, Intact Renal Function, and C5b-9 Deposition in colon and skin. J Hematol 4:193\u2013195","journal-title":"J Hematol"},{"key":"4039_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.9734\/IJMPCR\/2015\/18771","volume":"4","author":"TN Webb","year":"2015","unstructured":"Webb TN, Griffiths H, Miyashita Y, Bhatt R, Jaffe R, Moritz M, Hofer J, Swiatecka-Urban A (2015) Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with eculizumab. Int J Med Pharm Case Reports 4:105\u2013112","journal-title":"Int J Med Pharm Case Reports"},{"key":"4039_CR55","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3109\/0886022X.2014.917574","volume":"36","author":"H Green","year":"2014","unstructured":"Green H, Harari E, Davidovits M, Blickstein D, Grossman A, Gafter U, Gafter-Gvili A (2014) Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab. Ren Fail 36:1119\u20131121","journal-title":"Ren Fail"},{"key":"4039_CR56","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00467-013-2591-8","volume":"29","author":"E Roman-Ortiz","year":"2014","unstructured":"Roman-Ortiz E, Mendizabal Oteiza S, Pinto S, Lopez-Trascasa M, Sanchez-Corral P, Rodriguez de Cordoba S (2014) Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH\/CFHR1 hybrid gene. Pediatr Nephrol 29:149\u2013153","journal-title":"Pediatr Nephrol"},{"key":"4039_CR57","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1681\/ASN.2006080811","volume":"18","author":"AL Sellier-Leclerc","year":"2007","unstructured":"Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA, Macher MA, Niaudet P, Guest G, Boudailliez B, Bouissou F, Deschenes G, Gie S, Tsimaratos M, Fischbach M, Morin D, Nivet H, Alberti C, Loirat C, French Society of Pediatric N (2007) Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. J Am Soc Nephrol 18:2392\u20132400","journal-title":"J Am Soc Nephrol"},{"key":"4039_CR58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20525","volume":"78","author":"MJ Borowitz","year":"2010","unstructured":"Borowitz MJ, Craig FE, Digiuseppe JA, Illingworth AJ, Rosse W, Sutherland DR, Wittwer CT, Richards SJ, Clinical Cytometry S (2010) Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom 78:211\u2013230","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4039-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-4039-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-4039-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T06:28:07Z","timestamp":1720506487000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-4039-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4039"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-4039-7","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"22 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Cassandra Formeck - funded by NIDDK T32 training grant.Dr. Agnieszka Swiatecka-Urban - funded by NIH grant R56HL127202.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}